FDA Inspection 1032323 — LifeShare Blood Centers

LifeShare Blood Centers — FEI 2377737

The FDA completed an inspection of LifeShare Blood Centers on Oct 18, 2017 in Lake Charles, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Oct 18, 2017
Fiscal Year
2018
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Lake Charles, LA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.